ClinicalTrials.gg
Not yet recruitingNCT07785271Updated Aug 25, 2026

Manual Therapy vs. Home Exercise in Myogenic TMD With Neck Pain

An interventional study of Manual Therapy Protocol and Rocabado 6x6 Home Exercise Program in Temporomandibular Joint Disorders and Neck Pain Musculoskeletal, sponsored by Pamukkale University. Not yet recruiting. Open to participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-08-25.

Sponsored by Pamukkale University · Not applicable, Interventional, and Treatment

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
34
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Study summary

Temporomandibular disorders (TMD) are common musculoskeletal conditions affecting the jaw joint and surrounding chewing muscles. Myogenic TMD specifically involves muscle pain and dysfunction, which is frequently accompanied by chronic neck pain due to the close anatomical and neurophysiological connections between the jaw and the cervical spine.

The purpose of this study is to compare the clinical effectiveness of two widely used physiotherapy interventions-a clinician-administered manual therapy protocol and a patient-conducted home exercise program-in individuals diagnosed with myogenic TMD and chronic neck pain. The main research question is to determine whether targeted manual therapy applied to both the temporomandibular and cervical regions yields superior improvements in pain, jaw and neck mobility, quality of life, and masseter muscle properties compared to the Rocabado 6x6 home exercise program alone.

  1. A total of 34 participants aged 18-45 years with myogenic TMD and chronic neck pain will be randomly allocated into two equal groups:

    Manual Therapy Group: Participants receive 6 individual treatment sessions (3 days per week for 2 weeks) consisting of soft tissue mobilization, trigger point therapy, myofascial release, and joint mobilization techniques applied to the jaw and neck regions.

  2. Exercise Group: Participants perform the standardized Rocabado 6x6 home exercise program 3 days per week for 2 weeks, with adherence monitored through daily exercise diaries.

All participants undergo comprehensive assessments at baseline and immediately following the 2-week intervention. Evaluated parameters include jaw and neck pain intensity (Visual Analog Scale), cervical and mandibular range of motion, cervical joint position sense, jaw proprioception, facial asymmetry, bruxism, TMD severity, movement-related fear (kinesiophobia), and quality of life. In addition, masseter muscle thickness and elasticity are objectively assessed using ultrasound imaging and elastography.

The findings of this trial aim to provide healthcare professionals with high-level evidence regarding effective, targeted physiotherapy strategies for managing myogenic TMD co-occurring with cervical pain.

02

Conditions studied

  • Temporomandibular Joint Disorders
  • Neck Pain Musculoskeletal
03

In context

Temporomandibular Joint Disorders

591 studies on the registry are indexed under Temporomandibular Joint Disorders; 149 are open to participants now.

This study's planned enrollment of 34 is below the median of 45 across 415 interventional studies indexed under Temporomandibular Joint Disorders.

Browse Temporomandibular Joint Disorders studies →

Lead sponsor

Pamukkale University is the lead sponsor of 342 studies on the registry; 61 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Presence of TMJ pain at rest,
  • TMJ pain persisting for at least 3 months,
  • Neck pain persisting for at least 3 months,
  • Willingness to participate in the study.

Exclusion criteria

Exclusion Criteria:

  • Any orthopedic and/or neurological condition that would preclude the assessments,
  • Cardiac history or surgery severe enough to preclude exercise,
  • Diagnosis of any psychiatric disorder,
  • Any condition precluding assessment or communication,
  • History of orthopedic surgery in any region,
  • Receipt of physiotherapy or any other treatment for the TMJ or spinal region within the previous 6 months,
  • Illiteracy,
  • A positive vertebrobasilar artery test.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
34 participants (estimated)

Study arms

  • Experimental
    Manual Therapy Group

    Procedure: Manual Therapy Protocol

  • Active comparator
    Rocabado Home Exercise Group

    Other: Rocabado 6x6 Home Exercise Program

Interventions

  • ProcedureManual Therapy Protocol

    Clinician-administered targeted manual therapy protocol applied to both the temporomandibular joint and cervical spine regions. The treatment includes soft tissue mobilization, myofascial release, trigger point therapy, and joint mobilization techniques. Administered in 6 individual treatment sessions over 2 weeks (3 sessions per week).

  • OtherRocabado 6x6 Home Exercise Program

    Standardized patient-conducted Rocabado 6x6 home exercise program focusing on mandibular and cervical posture, mobility, and muscular control. Performed 3 days per week for 2 weeks. Patient adherence and compliance are tracked using daily exercise logbooks.

06

What researchers measure

Primary outcomes

  1. Temporomandibular Joint Pain Intensity at Rest, During Activity, and During Chewing Assessed by Visual Analog Scale (VAS).

    Time frame: Baseline and Week 2, immediately post-treatment

  2. Title: Neck Pain Intensity Assessed by Visual Analog Scale (VAS).

    Time frame: Baseline and 2 weeks post-treatment

Secondary outcomes

  1. Cervical Spine Active Range of Motion Assessed by Baseline CROM Deluxe Device.

    Time frame: Baseline and 2 weeks post-treatmen

  2. Cervical Joint Position Error Assessed by Baseline CROM Deluxe Device

    Time frame: Baseline and 2 weeks post-treatmen

  3. Mandibular Range of Motion Assessed by Digital Caliper

    Time frame: Baseline and 2 weeks post-treatment

  4. Jaw Proprioception Assessed by Active Movement Extent Discrimination Apparatus (AMEDA) Protocol.

    Time frame: Baseline and 2 weeks post-treatment

  5. Facial Asymmetry Assessed by Tape Measure

    Time frame: Baseline and 2 weeks post-treatment

  6. Kinesiophobia Assessed by Tampa Scale for Kinesiophobia for Temporomandibular Disorders - Short Form (TSK-TMD-12).

    Time frame: Baseline and 2 weeks post-treatment

  7. Health-Related Quality of Life Assessed by 12-Item Short Form Survey (SF-12).

    Time frame: Baseline and 2 weeks post-treatment

  8. Self-Reported Awake and Sleep Bruxism Assessed by Patient Questionnaire.

    Time frame: Baseline and 2 weeks post-treatment

  9. Temporomandibular Disorder Severity Assessed by the Fonseca Anamnestic Index (FAI) / Fonseca Questionnaire.

    Time frame: Baseline and 2 weeks post-treatment

  10. Bilateral Masseter Muscle Thickness Assessed by Ultrasonography.

    Time frame: Baseline and 2 weeks post-treatment

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2026; primary completion for Jan 2027, 4 months later.

Of 242 non-industry interventional studies with no phase under Temporomandibular Joint Disorders, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 21. This study's planned 4 months is below that.

Counting every sponsor, half of 246 studies reached it within 10 months; a quarter within 5 and three quarters within 21.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 18, 2026
First posted
Aug 25, 2026
StartEst.
Sep 1, 2026
Primary completionEst.
Jan 30, 2027
CompletionEst.
Feb 28, 2027
Last update
Aug 25, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 25, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07785271
Responsible party
Borna Farhoomand (Physiotherapist, Pamukkale University) — Principal investigator
First posted
Aug 25, 2026
Start date
Sep 1, 2026 (estimated)
Primary completion
Jan 30, 2027 (estimated)
Completion
Feb 28, 2027 (estimated)
Last update
Aug 25, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion